226 related articles for article (PubMed ID: 2557983)
1. Heterocyclic quinones. XVI. Pharmacomodulation in the series of 11H-indolo[3,2-c]quinolinediones: synthesis, cytotoxicity and antitumor activity of 3-substituted 11H-pyrido[3',4':4,5]pyrrolo[3,2-c]quinoline-1,4-diones.
Helissey P; Giorgi-Renault S; Renault J; Cros S
Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2413-6. PubMed ID: 2557983
[TBL] [Abstract][Full Text] [Related]
2. Heterocyclic quinones. XIV. Pharmacomodulation in a series of 11H-indolo[3,2-c]quinolinediones: synthesis and cytotoxicity of 8-substituted 11H-indolo[3,2-c]quinoline-7,10-diones.
Helissey P; Giorgi-Renault S; Renault J; Cros S
Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):675-9. PubMed ID: 2752476
[TBL] [Abstract][Full Text] [Related]
3. A convenient synthesis of 1H-pyrrolo[3,2-c]quinoline-6,9-diones and 11H-indolo[3,2-c]quinoline-1,4-diones derivatives.
Helissey P; Parrot-Lopez H; Renault J; Cros S
Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3547-57. PubMed ID: 3435963
[No Abstract] [Full Text] [Related]
4. Synthesis, antitumor evaluation and SAR of new 1H-pyrrolo [3,2-c] quinoline-6,9-diones and 11H-indolo [3,2-c] quinoline-1,4-diones.
Helissey P; Cros S; Giorgi-Renault S
Anticancer Drug Des; 1994 Feb; 9(1):51-67. PubMed ID: 8141966
[TBL] [Abstract][Full Text] [Related]
5. Structure-mutagenicity relationships in series of 11H-indolo[3,2-c]quinoline-1,4-diones, tetrahydro-11H-indolo[3,2-c]quinoline-1,4-diones and 11H-pyrido[3',4':4,5]pyrrolo[3,2-c]quinoline-1,4-diones with leukemia cytotoxic properties. Relations with topoisomerase I inhibiting properties.
Callais F; Helissey P; Min S; Festy B; Giorgi-Renault S
Mutat Res; 1994 Nov; 311(1):149-56. PubMed ID: 7526168
[TBL] [Abstract][Full Text] [Related]
6. 1-Amino-substituted 4-methyl-5H-pyrido[3',4':4,5]pyrrolo[3,2-c]pyridines: a new class of antineoplastic agents.
Nguyen CH; Bisagni E; Pepin O; Pierré A; de Cointet P
J Med Chem; 1987 Sep; 30(9):1642-7. PubMed ID: 3625709
[TBL] [Abstract][Full Text] [Related]
7. Silver- and gold-mediated domino transformation: a strategy for synthesizing benzo[e]indolo[1,2-a]pyrrolo/pyrido[2,1-c][1,4]diazepine-3,9-diones.
Zhou Y; Li J; Ji X; Zhou W; Zhang X; Qian W; Jiang H; Liu H
J Org Chem; 2011 Mar; 76(5):1239-49. PubMed ID: 21291254
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of pyridino[2,3-f]indole-4,9-dione and 6,7-disubstituted quinoline-5,8-dione derivatives and evaluation on their cytotoxic activity.
Suh ME; Park SY; Lee CO
Bioorg Med Chem; 2001 Nov; 9(11):2979-86. PubMed ID: 11597479
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitumor activity of fused quinoline derivatives. V. Methylindolo[3,2-b]quinolines.
Takeuchi Y; Kitaomo M; Chang MR; Shirasaka S; Shimamura C; Okuno Y; Yamato M; Harayama T
Chem Pharm Bull (Tokyo); 1997 Dec; 45(12):2096-9. PubMed ID: 9433781
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antitumor activity of fused quinoline derivatives. III. Novel N-glycosylamino-indolo[3,2-b]quinolines.
Takeuchi Y; Chang MR; Hashigaki K; Tashiro T; Tsuruo T; Tsukagoshi S; Yamato M
Chem Pharm Bull (Tokyo); 1992 Jun; 40(6):1481-5. PubMed ID: 1394666
[TBL] [Abstract][Full Text] [Related]
11. [Research on substances with antineoplastic activity. XLVI. Synthesis of derivatives of 11H-benzo(e)-pyrrolo(1,2-a)-indole and 7H-benzo-(d,e)-pyrrolo-(1,2-a)-quinoline].
Vomero S; Chimenti F; Porretta GC; Giuliano R; Artico M
Farmaco Sci; 1972 Sep; 27(9):786-94. PubMed ID: 4666087
[No Abstract] [Full Text] [Related]
12. Synthesis and antiproliferative evaluation of 7-aminosubstituted pyrroloiminoquinone derivatives.
Bénéteau V; Pierré A; Pfeiffer B; Renard P; Besson T
Bioorg Med Chem Lett; 2000 Oct; 10(19):2231-4. PubMed ID: 11012036
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antitumor evaluation of novel monoindolyl-4-trifluoromethylpyridines and bisindolyl-4-trifluoromethylpyridines.
Jiang B; Xiong XN; Yang CG
Bioorg Med Chem Lett; 2001 Feb; 11(4):475-7. PubMed ID: 11229751
[TBL] [Abstract][Full Text] [Related]
14. Structure-mutagenicity relationships in a series of indolo[3,2-c]quinoline-1,4-diones that have shown cytotoxic properties on leukemia cells.
Min S; Helissey P; Callais F; Giorgi-Renault S; Festy B
Mutat Res; 1992 Oct; 280(4):225-31. PubMed ID: 1382223
[TBL] [Abstract][Full Text] [Related]
15. Design of antineoplastic agents based on the '2-phenylnaphthalene-type' structural pattern--synthesis and biological activity studies of 11H-indolo[3.2-c]quinoline derivatives.
He L; Chang HX; Chou TC; Savaraj N; Cheng CC
Eur J Med Chem; 2003 Jan; 38(1):101-7. PubMed ID: 12593920
[TBL] [Abstract][Full Text] [Related]
16. Pyrrolo[3,4-c]quinoline-1,3-diones as potent caspase-3 inhibitors. Synthesis and SAR of 2-substituted 4-methyl-8-(morpholine-4-sulfonyl)-pyrrolo[3,4-c]quinoline-1,3-diones.
Kravchenko DV; Kysil VM; Tkachenko SE; Maliarchouk S; Okun IM; Ivachtchenko AV
Eur J Med Chem; 2005 Dec; 40(12):1377-83. PubMed ID: 16169127
[TBL] [Abstract][Full Text] [Related]
17. Alpha 1-adrenoceptor reagents. Synthesis of some 5,6,11,11a-tetrahydro-1H-imidazo[1',5':1,6]pyrido and 5,6,11,11b-tetrahydro-1H-imidazo[1',5':1,2]pyrido[3,4-b]indole-1,3(2H) -diones.
Lopez-Rodriguez ML; Morcillo MJ; Benhamu B; Fernandez E; Serrano J; Orensanz L
Chem Pharm Bull (Tokyo); 1995 Jun; 43(6):941-6. PubMed ID: 7641312
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antitumor activity of fused quinoline derivatives. II. Novel 4- and 7-hydroxyindolo-[3,2-b]quinolines.
Yamato M; Takeuchi Y; Chang MR; Hashigaki K
Chem Pharm Bull (Tokyo); 1992 Feb; 40(2):528-30. PubMed ID: 1606653
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antineoplastic activity of phenyl-substituted benzenesulfonylhydrazones of 2-pyridinecarboxyaldehyde 1-oxide.
Loh W; Cosby LA; Sartorelli AC
J Med Chem; 1980 Jun; 23(6):631-4. PubMed ID: 7392030
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological activity of guanylhydrazones of 2- and 4-pyridine and 4-quinoline carboxaldehydes.
Foye WO; Almassian B; Eisenberg MS; Maher TJ
J Pharm Sci; 1990 Jun; 79(6):527-30. PubMed ID: 2395098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]